Effect of smoking status on progression-free and overall survival in non-small cell lung cancer patients receiving erlotinib or gefitinib: a meta-analysis

2015 ◽  
Vol 40 (6) ◽  
pp. 661-671 ◽  
Author(s):  
H. S. Sohn ◽  
J.-W. Kwon ◽  
S. Shin ◽  
H.-S. Kim ◽  
H. Kim
Sign in / Sign up

Export Citation Format

Share Document